MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Staged and simultaneous bilateral MRI-guided focused ultrasound treatment of essential tremor

R. Galimova, D. Nabiullina, S. Illarioshkin, I. Buzaev, S. Safin, G. Akhmadeeva (Ufa, Russian Federation)

Meeting: 2023 International Congress

Abstract Number: 1653

Keywords: Essential tremor(ET), Thalamotomy, Ventralis intermedius nucleus(VIM)

Category: Surgical Therapy: Other Movement Disorders

Objective: The study aims to show that effective and safe bilateral MRgFUS treatment of ET is achievable.

Background: Unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy reduces or eliminates contralateral symptoms in patients with drug-refractory essential tremor (ET). Meanwhile, the disease usually manifests as a bilateral tremor, so unilateral MRgFUS treatment only partially improves the quality of life and performance. We present the first in our country experience of staged bilateral and the world’s first experience of single-stage simultaneous bilateral MRgFUS thalamotomy treatment of ET.

Method: We performed a bilateral thalamotomy in four cases with severe, drug-resistant ET in the V. S. Buzaev International Medical Center using INSIGHTEC’s neurosurgery EXABLATE 4000 system. Two patients have got staged MRgFUS treatments with an interval of more than 12 months. Two patients have got a single-staged simultaneous procedure. The target of focused ultrasound in all four patients was the thalamus’s ventral intermedial (VIM) nucleus. We used the Clinical Rating Scale for Tremor (CRST) to evaluate the treatment’s effect. In addition to assessing the side effects of MRgFUS by a neurologist, the patient monitored himself for adverse reactions and side effects during the operation in real time after each ultrasound sonication exposure.

Results: The results of ET treatment with MRgFUS bilateral thalamotomy are in Table 1 [table1]. All four patients noted a significant reduction in symptoms on both sides six months after both sides’ staged or simultaneous treatment. CRST scale tremor severity decreased from 56 to 18 points, 40 to 17 points, 60 to 19 points, and 59 to 19 points. Thus, the overall severity of hyperkinesis at the 6-month follow–up decreased by 57.5-68.3%. At the same time, the decrease in tremor in the extremities was even more significant – from 56.2% to 100%. After six months, all patients reported significantly reduced symptoms on both sides. [figure1].

Conclusion: Our experience shows that bilateral MRgFUS treatment of ET can be performed effectively and without complications. Further research is needed to determine the effectiveness and safety indicators.

Table.1.

[figure1]

To cite this abstract in AMA style:

R. Galimova, D. Nabiullina, S. Illarioshkin, I. Buzaev, S. Safin, G. Akhmadeeva. Staged and simultaneous bilateral MRI-guided focused ultrasound treatment of essential tremor [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/staged-and-simultaneous-bilateral-mri-guided-focused-ultrasound-treatment-of-essential-tremor/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/staged-and-simultaneous-bilateral-mri-guided-focused-ultrasound-treatment-of-essential-tremor/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley